it is possible that estrogens may increase the risk of a thromboembolic event due to an adverse influence on coagulation parameters and , at the same time , decrease the risk of an atherogenic event ( via favorably altered lipid/lipoprotein levels ) .
C0014939
estrogens
C0040038
thromboembolic